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Summary.-Experiments were undertaken to study the effect ofpromotion treatment
on epidermal tumour induction pattern in precancerous mouse skin. Swiss albino
mice were given a single s.c. injection of 0-5 mg 20-methylcholanthrene in the right
scapular region. Six weeks later, 1 83 nmol of phorbol myristate acetate (PMA) was
applied biweekly onthe reactive skin. Histopathology oftheinduced tumours showed
early appearance of squamous cell carcinomas and rhabdomyosarcomas. Fibro-
sarcoma, the most common tumour type induced on MCA injection alone, was
absent. Trichoepithelioma, a benign tumour, was induced in PMA-treated mice.
This gives new evidence of the selective action of PMA, enhancing the induction of
epithelial and muscle tumours, with concurrent inhibition of fibroblastic tumours.
THE EVENTS related to tumour pro-
motion are understood better since the
isolation and chemical characterization of
active promoting agents by Hecker (1968)
and Van Duuren (1969). The availability
ofpure promoter substances led to detailed
studies of the biological attributes of
tumour promotion (Raick, Thumm and
Roy Chivers, 1972; Raick, 1973; Van
Duuren et al., 1973; Baird and Boutwell,
1971). Although the promoting abilities
of croton oil and phorbol esters have been
tested by the two-stage technique (Beren-
blum and Shubik, 1947; Berenblum, 1954;
Van Duuren et al., 1973; Raick et al.,
1972; Baird and Boutwell, 1971), the
tumour induction pattern using the three-
stage technique has been studied by few
workers (Hennings and Boutwell, 1970;
Salaman, 1952). The experiments pre-
sented in this communication were carried
out to determine the effect of the well-
known tumour promoter, phorbol myri-
state acetate (PMA), on the incidence of
epidermal tumour induction in the pre-
cancerous skin of Swiss albino mice given
a single s.c. injection of 20-methyleholan-
threne (MCA). In the experiments re-
ported here, a completely carcinogenic
dose ofMCA is used to obtain precancerous
mouse skin (Bhisey and Sirsat, 1966). A
low dose ofPMA is used for the promotion
of latent tumour cells into overt tumours.
Data on the tumour induction pattern
with PMA or acetone is compared with
our published (Bhisey and Sirsat, 1966)
and unpublished observations on tumours
induced with one s.c. injection of MCA.
MATERIALS AND METHODS
Animals.-Six-week-old inbred male and
female Swiss albino mice were used. This
strain, obtained originally from the Rocke-
feller Institute, New York, U.S.A., has
completed several generations of controlled
inbreedingf at the Animal Colony of the
Cancer Research Institute, Bombay. The
animals were kept on an adequate protein
diet and water was given ad libitum.
Chemicals. 20-Methylcholanthrene
(MCA) was obtained from Koch. Light and
Co. Ltd, England. The carcinogen was
dissolved in thiophene-free benzene to a
concentration of 0 25%. Phorbol myristate
acetate (PMA) was obtained through theR. A. BHISEY AND S. M. SIRSAT
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courtesy of Dr B. L. Van Duuren of New
York University Medical Centre, New York,
N.Y., U.S.A. PMA was dissolved in acetone
to a concentration of 1-83 nmol in 0 1 ml.
Treatment.-For tumour induction, all
the animals were given a single s.c. injection
of 0-2 ml thiophene-free benzene containing
0.5 mg MCA in the right scapular region.
This dose of AICA is known to induce epi-
dermal tumours in a large number of mice
without causing mortality (Bhisey and Sirsat,
1966). Carcinogen-injected animals were
divided in the initial experiment into 3
groups. Animals in Group I received no
further treatment. Mice in Groups II and
III were treated as follows. Six weeks after
MCA injection, hair at the site of injection
was shaved, using an electric clipper. Forty-
eight hours later, 0.1 ml of acetone was
applied biweekly with a tuberculin syringe to
the reactive skin surface of the animals in
Group II (solvent controls), and 1-83 nmol of
PMA in 0-1 ml acetone was administered
biweekly to the animals in Group III. These
treatments, as well as the killing of animals,
were carried out between 10 and 11 a.m.
Biweekly application of PMA or acetone was
continued until the development of palpable
tumours without necrosis, and the mice were
sacrificed by ether anaesthesia 48 h after the
last treatment. PMA treatment was repeated
in 12 MCA-injected Swiss albino mice. These
animals constitute Group IV. The tumours
were collected in 10% Lillie's buffered neutral
formalin and cut into smaller pieces. Paraffin
sections (5 ,um) were stained by haematoxylin
and eosin or by Mallory's trichrome staining
technique.
RESULTS
The histological type of various
tumours obtained after a single s.c.
injection ofMCA, and followed by acetone
or PMA is given in the Table. The
malignant tumour types induced in Group
I animals (MCA alone) are fibrosarcomas,
squamous cell carcinomas and rhabdo-
myosarcomas, in the decreasing order of
frequency. Further biweekly application
of acetone to the animals in Group II
does not alter the tumour induction
pattern. However, PMA-treated mice in
Groups III and IV show a distinct altera-
tion in the tumour types. In these
animals, the identical findings of signifi-
cance are (1) total absence of fibrosar-
comas, (2) enhancement of rhabdomyo-
sarcomas and (3) development of tricho-
epitheliomas. Twelve weeks after the
initial exposure to MCA alone, 44%
(19/43) mice developed palpable tumours,
while the percentage of tumour-bearers
rose to 63% (24/38 mice) on PMA treat-
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FIG.-Comparison of tumours induced in Swiss albino mice given a single injection of 0 5 mg
MCA, with those also treated with PMA
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ment at this time period. The Fig.
compares the histologically divergent
tumours induced with MCA alone with
those obtained in mice subsequently
treated with PMA.
Twelve weeks after initial exposure to
the carcinogen alone, 10 fibrosarcomas, 4
squamous cell carcinomas, 3 rhabdomyo-
sarcomas and 6 sebaceous cysts were
obtained. During the same period, no
fibrosarcomas, 11 squamous cell carci-
nomas, 12 rhabdomyosarcomas, 6 seba-
ceous cysts and 3 trichoepitheliomas arose
in PMA-treated mice. Trichoepitheliomas
continued to develop between 81 and 24
weeks after initial carcinogen treatment.
Only 3 out of 12 trichoepitheliomas
occurred singly, the rest being mixed
tumours with squamous cell carcinomas or
rhabdomyosarcomas.
DISCUSSION
The spontaneous tumour incidence in
the mouse strain used in this study is very
low, and includes alveolar carcinomas and
inflammatory changes in the ovary. MCA
as well as PMA and acetone in the
concentrations employed in this study, did
not increase the incidence ofspontaneously
occurring tumour types.
The promoting range of TPA (tetra-
decanoyl phorbolacetate) or PMA has been
found to be 0-0016-0-016 ,amol applied per
week or biweekly (Raick et al., 1972;
Baird and Boutwell, 1971). Application
of phorbol esters to initiated mouse skin
increases the number of papillomas in-
duced as a function oftime, the promoting
action being dose-dependent (Baird and
Boutwell, 1971; Raick et al., 1972; Van
Duuren et al., 1973) and several palpable
tumours develop in a single mouse. When
MCA is injected s.c., a single palpable
growth containing more than one histo-
pathological tumour type is often obtained
(Bhisey and Sirsat, 1966). PMA-treated
mice also develop a single growth with
mixed histopathology at the site of
carcinogen injection. However, the earlier
appearance of sebaceous cysts, rhabdo-
myosarcomas and squamous cell carcino-
mas in PMA-treated mice, whencompared
to those in mice injected MCA alone,
indicates that this tumour promoter hast-
ens the progression of precancerous cells
into frankly malignant ones, by providing
a selective proliferative stimulus.
As observed in this study, tricho-
epithelioma induction requires long pro-
motion treatment, lasting up to 18 weeks.
Ofthe 12 tumours ofthis type, 3 appeared
between 8 and 12 PMA applications while
the remainder developed after 13 to 36
applications of PMA. Trichoepitheliomas
which develop as a result of enhanced
differentiation of epidermal cells into hair
follicles are not known to undergo malig-
nant changes (Hashimoto and Lever,
1971) and do not occur in MCA-injected
mice in the absence of promotion with
PMA. This indicates that s.c. MCA
provides a feeble promoting stimulus
with respect to epidermal carcinogenesis.
Topical application of PMA effectively
transforms the initiated epidermal cells
into a benign lesion.
Focal areas of extensive fibroblastic
proliferation in mouse skin treated with
PMA were observed by Raick et al. (1972).
Sivak (1974) has shown that PMA causes
preferential outgrowth of SV40-trans-
formed 3T3 cells in the presence of a large
number of untransformed cells. He sug-
gested that a similar situation may occur
in vivo in mouse skin. The reasons for the
total inhibition of fibrosarcomas on PMA
application are not understood. This
phenomenon points to the initiation by
PMA ofmolecular events which render the
promoting influence of MCA ineffective,
depriving precancerous fibroblasts oftheir
rapid selective growth potential. An
increase in the number of rhabdomyosar-
comas, and their early occurrence on
exposure to the tumour-promoter, show
that PMA causes selective proliferation
of muscle cells rendered precancerous by
MCA.
The tumour induction data obtained
in this study favours the multiphasic
process of s.c. induced chemical carcino-
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genesis in the mouse skin. Although epi-
thelial cells, fibroblasts as well as muscle
cells, are transformed to a precancerous
state 6 weeks after exposure to MCA,
PMA application results in early selective
propagation of precancerous epithelial
and muscle cells into malignant tumours,
and complete inhibition of fibrosarcomas.
In the induction of trichoepitheliomas,
however, both phases of tumour,
promotion appear to be involved. The
modified tumour induction pattern ob-
tained on PMA treatment suggests that
in a tissue, although different cell types
may be transformed by a carcinogen, the
promoting stimulus decides decisively
which of these will progress further into a
frank neoplasm.
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